In this phase @b , double-blind , placebo-controlled study , treatment-naive adults with genotype @ ( n = @ ) or @ ( n = @ ) were randomly assigned ( @:@ ) to asunaprevir @mg or placebo twice daily plus PegIFN/RBV .